BioLineRx and Hemispherian AS Form JV to Develop GLIX1 for Cancer
September 29, 2025
BioLineRx Ltd., a clinical-stage biopharmaceutical company that specializes in oncology and rare diseases, has joined forces with Hemispherian AS, a Norwegian biotech firm that focuses